No Data
No Data
Organon, Henlius Say EMA Validates Marketing Authorization Application for Proposed Breast Cancer Drug
Express News | European Medicines Agency (EMA) Validates Henlius and Organon Filing for Perjeta® (Pertuzumab) Biosimilar Candidate Hlx11
Organon (OGN) Advances While Market Declines: Some Information for Investors
The tariff war between the US and Europe is escalating, and Trump's 'tariff big stick' is making the pharmaceutical industry tremble.
Pharmaceutical companies are urging the Trump administration and EU officials to exclude Medical products from the escalation of the trade war.
Barclays Maintains Organon & Co(OGN.US) With Buy Rating, Maintains Target Price $24
Express News | Reported Saturday, Organon's VTAMA Phase 3 Data Shows 84% Of Patients Maintained Mild Disease After 80-Day Off-Treatment Interval In Adults And Children 2+